Immunome
IMNM
#4802
Rank
A$3.01 B
Marketcap
A$25.51
Share price
-2.44%
Change (1 day)
-8.65%
Change (1 year)

Earnings for Immunome (IMNM)

Earnings in 2026 (TTM): -A$0.4 Billion

According to Immunome's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.34 Billion a decrease over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunome from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.4 Billion19.77%
2025 -A$0.34 Billion46.04%
2024 -A$0.23 Billion434.17%
2023 -A$42.66 Million-22.15%
2022 -A$54.79 Million46.39%
2021 -A$37.43 Million41.63%
2020 -A$26.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-42.27%๐Ÿ‡บ๐Ÿ‡ธ USA